Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas

Matthias P.A. Ebert, Fabian Model, Suzanne Mooney, Kari Hale, Joe Lograsso, Lori Tonnes-Priddy, Juliane Hoffmann, Antal Csepregi, Christoph Röcken, Bela Molnar, Hans Ulrich Schulz, Peter Malfertheiner, Catherine Lofton-Day

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Background & Aims: The identification of novel genetic and epigenetic markers indicative of changes in the pathogenesis of colon cancer, along with easier-to-use, more sensitive assay methods, may improve the detection, treatment, and overall prognosis of this malignancy. Methods: Using methylation-specific arbitrarily primed polymerase chain reaction, a fragment of the Aristaless-like homeobox-4 (ALX4) gene that was highly methylated in colon adenomas and cancer was identified. Methylation of ALX4 was analyzed in colorectal adenomas and cancers, in the liver metastases of patients with colorectal cancer, and in 61 other neoplasias, including gastric, esophageal, and hepatocellular cancer and cholangiocarcinoma. ALX4 methylation was also analyzed in the serum of 30 patients with colon cancer. Results: ALX4 gene methylation was confirmed in colon adenomas (11/13) and more frequently present in primary colorectal cancers (30/47) compared with the normal colon mucosa (0/21) (P < .0001). In addition, ALX4 methylation was frequently observed in adenocarcinomas of the esophagus (12/14), stomach (11/15), and bile ducts (4/5) compared with all other cancers (P < .001). ALX4 gene methylation was also more frequently found in sera of patients with colon cancer compared with noncancer controls (P < .0001). Using a cutoff of 41.4 pg/mL, sensitivity and specificity were 83.3% and 70%, respectively. Conclusions: Apart from colon adenomas and primary and metastatic colorectal cancers, ALX4 is frequently methylated in adenocarcinomas of the gastrointestinal tract. ALX4 gene methylation in sera of patients with cancer may thus serve as a methylation-specific test for colon and other gastrointestinal cancers.

Original languageEnglish
Pages (from-to)1418-1430
Number of pages13
JournalGastroenterology
Volume131
Issue number5
DOIs
Publication statusPublished - Nov 2006

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas'. Together they form a unique fingerprint.

  • Cite this

    Ebert, M. P. A., Model, F., Mooney, S., Hale, K., Lograsso, J., Tonnes-Priddy, L., Hoffmann, J., Csepregi, A., Röcken, C., Molnar, B., Schulz, H. U., Malfertheiner, P., & Lofton-Day, C. (2006). Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas. Gastroenterology, 131(5), 1418-1430. https://doi.org/10.1053/j.gastro.2006.08.034